Nanoparticles to Cross Biological Barriers - Biomaterials Science: An Integrated Clinical and Engineering Approach - page 110

20. R.B. Greenwald, Y.H. Choe, J. McGuire, C.D. Conover, Effective drug delivery
by PEGylated drug conjugates, Adv. Drug Deliv. Rev. 55 (2003) 217-250.
21. C. Li, S. Wallace, Polymer-drug conjugates: Recent development in clinical
oncology, Adv. Drug Deliv. Rev. 60 (2008) 886-898.
22. D.A. LaVan, D.M. Lynn, R. Langer, Moving smaller in drug discovery and deliv-
ery, Nat Rev Drug Discov 1 (2002) 77-84.
23. L.E. Euliss, J.A. DuPont, S. Gratton, J. DeSimone, Imparting size, shape, and
composition control of materials for nanomedicine, ChemInform 38 (2007)
1095-1104.
24. R. Weissleder, K. Kelly, E.Y. Sun, T. Shtatland, L. Josephson, Cell-specific target-
ing of nanoparticles by multivalent attachment of small molecules, Nat Biotech
23 (2005) 1418-1423.
25. M. Grzelczak, J. Perez-Juste, P. Mulvaney, L. Liz-Marzan, Shape control in gold
nanoparticle synthesis, Chem. Soc. Rev. 37 (2008) 1783-1791.
26. B.D. Chithrani, A.A. Ghazani, W.C.W. Chan, Determining the size and shape
dependence of gold nanoparticle uptake into mammalian cells, Nano Letters 6
(2006) 662-668.
27. N.R. Jana, Shape effect in nanoparticle self-assembly, Angewandte Chemie 116
(2004) 1562-1566.
28. S.E.A. Gratton, P.A. Ropp, P.D. Pohlhaus, J.C. Luft, V.J. Madden, M.E. Napier,
J.M. DeSimone, The effect of particle design on cellular internalization path-
ways, Proceedings of the National Academy of Sciences 105 (2008) 11613-11618.
29. J.P. Rolland, B.W. Maynor, L.E. Euliss, A.E. Exner, G.M. Denison, J.M. DeSimone,
Direct fabrication and harvesting of monodisperse, shape-specific nanobioma-
terials, J. Am. Chem. Soc. 127 (2005) 10096-10100.
30. V. Labhasetwar, C. Song, W. Humphrey, R. Shebuski, R.J. Levy, Arterial uptake
of biodegradable nanoparticles: Effect of surface modifications, Journal of
Pharmaceutical Sciences 87 (1998) 1229-1234.
31. Y. Yamamoto, Y. Nagasaki, Y. Kato, Y. Sugiyama, K. Kataoka, Long-circulating
poly(ethylene glycol)-poly(-lactide) block copolymer micelles with modulated
surface charge, J. Controlled Release 77 (2001) 27-38.
32. S.J. Clarke, C.A. Hollmann, F.A. Aldaye, J.L. Nadeau, effect of ligand density
on the spectral, physical, and biological characteristics of CdSe/ZnS quantum
dots, Bioconjug. Chem. 19 (2008) 562-568.
33. S. Nagayama, K. Ogawara, Y. Fukuoka, K. Higaki, T. Kimura, Time-dependent
changes in opsonin amount associated on nanoparticles alter their hepatic
uptake characteristics, Int. J. Pharm. 342 (2007) 215-221.
34. C. Fang, B. Shi, Y. Pei, M. Hong, J. Wu, H. Chen, In vivo tumor targeting of
tumor necrosis factor-α-loaded stealth nanoparticles: Effect of MePEG molecu-
lar weight and particle size, European Journal of Pharmaceutical Sciences 27 (2006)
27-36.
35. J.B. Haun, D.A. Hammer, Quantifying nanoparticle adhesion mediated by spe-
cific molecular interactions, Langmuir 24 (2008) 8821-8832.
36. C. Chen, E.E. Dormidontova, Architectural and structural optimization of the
protective polymer layer for enhanced targeting, Langmuir 21 (2005) 5605-5615.
37. F. Gu, L. Zhang, B.A. Teply, N. Mann, A. Wang, A.F. Radovic-Moreno, R. Langer,
O.C. Farokhzad, Precise engineering of targeted nanoparticles by using self-
assembled biointegrated block copolymers, Proceedings of the National Academy
of Sciences 105 (2008) 2586-2591.